AN ANALYSIS OF TREATMENT PATTERNS IN KNEE OSTEOARTHRITIS IN A U.S. ADMINISTRATIVE CLAIMS DATABASE

Author(s)

Bonafede M1, Vlahiotis A2, Wu J3, Marchlewicz E4, Bedenbaugh A5, Lee V6, Tambiah J6
1IBM Watson Health, Brentwood, NH, USA, 2IBM Watson Health, Manchester, MO, USA, 3IBM Watson Health, Cambridge, MA, USA, 4IBM Watson Health, Ann Arbor, MI, USA, 5Samumed, Douglasville, GA, USA, 6Samumed, San Diego, CA, USA

OBJECTIVES : Knee osteoarthritis (OA) is a prevalent and disabling joint disease with substantial economic burden. This study describes treatment patterns for patients with new knee OA diagnosis.

METHODS : A retrospective cohort study was performed using U.S. administrative claims data from 2011-2018 (IBM MarketScan®). Inclusion criteria included age ≥ 18 and ≥ 1 claim with ICD-10 diagnosis of knee OA. Index date was the earliest ICD-10 knee OA diagnosis or ICD-9-CM diagnosis for lower-leg OA with > 2 years prior continuous enrollment without these diagnoses. The primary outcome was receipt of knee OA treatments, stratified by diagnosing physician type.

RESULTS : The study included 488,510 new knee OA patients (mean age 60.5 years [SD 12.2]; 60% female). The two most common diagnosing physician types were orthopedic surgeons (OS [48%]) and general practitioners (GP [20%]); however, 32% were other/unknown. Among newly diagnosed knee OA patients, 68.3% received corticosteroids, 53.9% received opioids (one-year mean days supply = 74.7 days), 52.2% received prescription NSAIDs, and 19.5% received hyaluronic acid. OS-diagnosed patients received more medications and had shorter initiation times than GP-diagnosed patients with the greatest difference for hyaluronic acid (1.62 times more; median time to initiation of 63 versus 91 days) and corticosteroids (1.19 times more; median time to initiation of 0 days versus 17 days). 11.7% of all patients received a knee-OA-related procedure. 11.4% received total knee replacements, with OS-diagnosed patients 1.55 times more likely to get replacements and had shorter median time to procedure (272 versus 346 days) compared to GP-diagnosed patients.

CONCLUSIONS : This descriptive analysis found that knee OA patients diagnosed by OS received more knee-OA-related procedures and earlier prescriptions than patients diagnosed by GPs. Opioids and NSAIDs were common regardless of diagnosing physician type. Future research should further explore potential drivers of the variations in treatment pathways observed in this study.

Conference/Value in Health Info

2019-05, ISPOR 2019, New Orleans, LA, USA

Value in Health, Volume 22, Issue S1 (2019 May)

Code

PSY18

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Treatment Patterns and Guidelines

Disease

Drugs, Musculoskeletal Disorders, Surgery, Systemic Disorders/Conditions

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×